Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Belinostat by Acrotech Biopharma for Natural Killer Cell Lymphomas: Likelihood of Approval
Belinostat is under clinical development by Acrotech Biopharma and currently in Phase III for Natural Killer Cell Lymphomas. According to...
Belinostat by Acrotech Biopharma for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
Belinostat is under clinical development by Acrotech Biopharma and currently in Phase I for Diffuse Large B-Cell Lymphoma. According to...
Belinostat by Acrotech Biopharma for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
Belinostat is under clinical development by Acrotech Biopharma and currently in Phase I for Diffuse Large B-Cell Lymphoma. According to...